Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review

Jun Watanabe1, Masato Hamasaki1, Kazuhiko Kotani1

  • 1Division of Community and Family Medicine, Jichi Medical University, Shimotsuke-City, Japan.

Insights

High lipoprotein(a) (Lp[a]) levels significantly increase cardiovascular disease (CVD) risk in familial hypercholesterolemia (FH) patients. Monitoring Lp[a] alongside LDL-C is crucial for managing CVD risk in FH.

Area of Science:

  • Cardiology
  • Genetics
  • Public Health

Background:

  • Lipoprotein(a) (Lp[a]) is a known risk factor for cardiovascular disease (CVD).
  • Familial hypercholesterolemia (FH) is characterized by elevated low-density lipoprotein cholesterol (LDL-C) and is also a CVD risk factor.
  • The interplay between Lp[a] and CVD risk specifically within FH populations requires further elucidation.

Purpose of the Study:

  • To systematically review and meta-analyze existing studies on the association between Lp[a] levels and CVD risk in individuals with FH.
  • To quantify the predictive value of high Lp[a] for CVD events in the FH cohort.

Main Methods:

  • A comprehensive literature search was conducted using PubMed for studies published up to 2020.
  • Eligible studies reporting on Lp[a] and CVD in FH subjects were included.
  • Meta-analyses were performed on cross-sectional and cohort studies.

Main Results:

  • Eight studies met the inclusion criteria.
  • High Lp[a] was significantly associated with increased CVD risk in both cross-sectional (OR=2.57) and cohort (HR=1.91) studies.
  • The integrated relative risk for CVD associated with high Lp[a] in FH was 1.97 (95% CI: 1.57-2.46).

Conclusions:

  • Individuals with FH and elevated Lp[a] levels face a substantial risk of developing CVD.
  • Lp[a] should be considered a critical risk marker in FH management, in addition to LDL-C.
  • Clinical attention to Lp[a] levels can aid in refining CVD risk stratification and prevention strategies for FH patients.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
246
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
586
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.2K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
510
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
477